Earnings History Data for Aerovate Therapeutics, Inc. (AVTE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Aerovate Therapeutics, Inc.
Aerovate Therapeutics Inc. is a clinical stage biopharmaceutical company. It focused on developing drugs for cardiopulmonary disease. The company's product pipeline consist AV-101. Aerovate Therapeutics Inc. is based in BOSTON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-05-2024 | AH | AVTE | Aerovate Therapeutics | 602.00 | -0.83 | -0.74 | 0.00 | Aerovate Therapeutics reports Q1 GAAP EPS of -$0.83 [5/14/2024 12:34 PM] |
19.40 | 0.26 (1.36%) |
19.14 | 0.0 (0.00%) |
9.41 - 32.42 | 229,553 | 130,000 | 2,026 | ||
| 25-03-2024 | AH | AVTE | Aerovate Therapeutics | 719.00 | -0.74 | -0.68 | 0.00 | Aerovate Therapeutics reports FY results [3/25/2024 5:59 PM] |
25.68 | -1.27 (-4.69%) |
27.01 | 0.06 (0.22%) |
9.41 - 28.39 | 255,919 | 150,000 | 1,058 | ||
| 14-08-2023 | PM | AVTE | Aerovate Therapeutics | 416.00 | -0.76 | -0.69 | 0.00 | Aerovate Therapeutics GAAP EPS of -$0.76 [8/14/2023 9:16 AM] |
14.97 | -0.34 (-2.22%) |
0.0 | 0.0 (0.00%) |
13.81 - 30.79 | 94,690 | 70,000 | 0 | ||
| 15-05-2023 | PM | After the close (May 15) |
AVTE | Aerovate Therapeutics, Inc. | 516.15 | -0.67 | -0.58 | -0.45 | Aerovate Therapeutics GAAP EPS of -$0.67 misses by $0.07 [5/16/2023 4:18 AM] |
19.60 | -1.48 (-7.02%) |
0.0 | 0.0 (0.00%) |
11.13 - 30.79 | 37,738 | 60,000 | 0 | |
| 14-11-2022 | PM | AVTE | Aerovate Therapeutics | 492.00 | -0.56 | -0.50 | 0.00 | Aerovate Therapeutics GAAP EPS of -$0.56 misses by $0.06 [11/14/2022 9:14 AM] |
19.25 | -0.11 (-0.57%) |
19.36 | 0.0 (0.00%) |
7.74 - 27.83 | 44,672 | 70,000 | 311 | ||
| 16-05-2022 | PM | Before the open (May 16) |
AVTE | Aerovate Therapeutics | 288.00 | -0.45 | -0.26 | 0.00 | Aerovate Therapeutics GAAP EPS of -$0.45 misses by $0.17 [5/16/2022 9:49 AM] |
11.54 | -1.53 (-11.71%) |
13.07 | 0.0 (0.00%) |
7.74 - 29.43 | 20,837 | 80,000 | 1,140 | |